Semaglutide Side Effects Week by Week

Semaglutide is a long-acting GLP-1 research compound with a half-life of about 7 days. That slow clearance shapes the whole side-effect timeline. Levels rise gradually after each weekly dose, build over several weeks, and never fully clear between injections. This is general reference information for research and educational use only, not medical advice. Peptides are not approved for human consumption, and any real protocol belongs with a licensed clinician.

The reported pattern is consistent: digestive effects tend to lead, they often spike in the first days after a dose, and every titration step can reset the cycle. Below is how that usually maps across weeks. To see how each labeled dose translates into a fill volume and syringe units, run your numbers through the semaglutide calculator.

Why the half-life drives the timeline

With a 7-day half-life, semaglutide reaches steady state only after roughly 4 to 5 weeks at a fixed dose. Each weekly injection lands on top of what is left from the last one, so blood levels climb in a stair-step. Most reported side effects track that climb, which is why the early weeks of any new dose tend to feel the strongest.

The within-week onset and peak

After a single weekly dose, plasma levels do not spike instantly. They rise over 1 to 3 days and reach a peak around day 1 to 3, then taper toward the next injection. Many users report digestive effects clustering in those first 24 to 72 hours, then easing later in the week. That gives a predictable rhythm: heavier days right after the shot, lighter days before the next one.

Week by week reference pattern

• Week 1 (often 0.25 mg start): Mild nausea, fullness, or burping commonly reported in the first days after the dose. This starting amount is typically described as non-therapeutic and used to let the gut adjust.
• Weeks 2 to 4 (holding the start dose): Many report effects settling as levels approach steady state. Constipation or reflux can show up as appetite drops and food intake changes.
• Week 5 (first titration step, often to 0.5 mg): The most common nausea flare. A higher dose restarts the climb to a new steady state, so the early-week spike tends to return for a few weeks.
• Weeks 6 to 8: Effects from the new dose usually ease as the body re-adjusts, mirroring the first month.
• Each later step up: The same reset repeats. Bigger jumps are associated with sharper flares in reports, which is the rationale for gradual increases.

The titration-step nausea pattern

The single most useful idea here: side effects are tied to change, not just dose size. Holding a dose tends to mean tolerance builds and effects fade. Stepping up restarts the 4-to-5-week climb to a new steady state, and the first 1 to 2 weeks of each step are where nausea reports concentrate. This is why standard titration schedules space increases about 4 weeks apart. For the general step sequence, the semaglutide dosage chart lays out the common 0.25, 0.5, 1.0, 1.7, and 2.4 mg ladder, and a broader week-by-week breakdown covers the same arc in more depth.

Common reported effects, by frequency

1. Nausea: the most reported, peaks early at each step.
2. Constipation and diarrhea: often appear as intake drops.
3. Reflux, burping, and early fullness: tied to slowed gastric emptying.
4. Fatigue and headache: usually mild and early.
5. Injection-site reactions: minor and short-lived in most reports.

A worked dosing example

Numbers matter because under-filling or over-filling a syringe changes the actual dose. Say a vial holds 5 mg of semaglutide reconstituted with 2 mL of bacteriostatic water. That is 2.5 mg per mL, or 0.25 mg per 0.1 mL. A 0.25 mg starting dose is 0.1 mL, which reads as 10 units on a U-100 insulin syringe. A 0.5 mg dose is 0.2 mL, or 20 units. Getting these conversions exact is what keeps a titration step from accidentally becoming a double step. Confirm every fill with the reconstitution calculator and read units off your syringe carefully.

How to think about the timeline

In research summaries, the arc looks like this: effects show up within days of a dose, cluster in the first 72 hours, fade as a dose is held, and flare again at the next step. Tracking which week and which dose you are on makes the pattern predictable instead of surprising. Log doses and notes in the Stackr app so each titration step is on record.

None of this replaces a clinician. Dose decisions, side-effect management, and whether semaglutide is appropriate at all are medical questions. See the disclaimer for the full scope of this educational content.